It was a good month for Ethema Health Corporation (OTCPINK: GRST) and with that also a hopeful end to a turbulent year that will go into the books as the year of the Covid-19. In late November, the company announced that it had signed a term sheet with Labrys Fund LP for a 12 percent loan valued at $275,000.00. This gives Ethema $239,050.00 net after original interest rebates, legal fees and brokerage fees. But this was by no means all of what was revealed this month.
One day after the term sheet was signed, Ethema received a conversion notification from Labrys. It involved a conversion of the original outstanding principal amount under the Note prior to a previous amendment requiring the company to repay a reduced principal amount of the Note in monthly cash installments. A great total of 91,421,457 shares were issued under this conversion.
The effects after Labrys were clearly visible
The company had a positive cash flow result from these events, which in three months amounted up to $325,000.00. In particular, the significant switch in the market and the new investment by Labrys showed that confidence in Ethema’s business had steadily increased, with particular attention being paid to the results of the restructuring transactions carried out by the company this year.
The forecast is that the resulting cash will be sufficient to meet Ethema’s operational cash flow requirements, which will lead to the start-up of a new addiction center. In addition, Regulation A Tier II financing will be pursued in order to support new acquisitions in the future.
Shortly thereafter, on December 10, news came that Ethema had filed an 8-K form and canceled the CEO shares. This application is used as a reference for the forthcoming Scheme A application. The term sheet with Labrys was closed and the final warrants that were issued turned out to be more attractive to Ethema than initially thought. The latest warrant was 100,000,000 shares, which is a big drop from the previous 183,333,333 shares. The exercise price also shifted from $0.0015 to $0.00205.
ARIA and Ethema went a step further in december
Finally, Ethema announced the Evernia Health Center LLC (ARIA) had begun its audit of the Department of Children and Families (DCF) that same day. ARIA is known for its great success in controlling the spread of Covid-19 thanks to the use of the Covid Clear product, the use of PPE and the many tests it conducts. The audit was quickly completed, giving ARIA the full license and ability to contract with certain insurance companies, significantly increasing the number of customers. ARIA has a lot to do, because it has already received the approval of LegitScript and Google to start the process surrounding the Pay Per Click (PPC) marketing.
Neither PSN nor its owners, members, officers, directors, partners, consultants, nor anyone involved in the publication of this website, is a registered investment adviser or broker-dealer or associated person with a registered investment adviser or broker-dealer and none of the foregoing make any recommendation that the purchase or sale of securities of any company profiled in the PSN website is suitable or advisable for any person or that an investment or transaction in such securities will be profitable. The information contained in the PSN website is not intended to be, and shall not constitute, an offer to sell nor the solicitation of any offer to buy any security. The information presented in the PSN website is provided for informational purposes only and is not to be treated as advice or a recommendation to make any specific investment. Please consult with an independent investment adviser and qualified investment professional before making an investment decision.